Meeting
2020 ASCO Virtual Scientific Program
Genomic characterization and outcome evaluation of kinome fusions in a large non-small cell lung cancer population.
Authors
Fengying Wu
Shanghai Pulmonary Hospital, Shanghai, China
Fengying Wu , Sisi Liu , Qiuxiang Ou , Hua Bao , Xue Wu , Yang Shao , Caicun Zhou
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 38: 2020 (suppl; abstr 9620)
DOI
10.1200/JCO.2020.38.15_suppl.9620
Abstract #
9620
Poster Bd #
386
Abstract Disclosures
Similar Posters
Poster
2015 ASCO Annual Meeting
Clinical implementation of anchored multiplex PCR with targeted next-generation sequencing for detection of ALK, ROS1, RET and NTRK1 fusions in non-small cell lung carcinoma.
First Author: Anna F. Farago
Poster
2014 ASCO Annual Meeting
Next-generation sequencing (NGS) to identify actionable genomic alterations (GA) in “pan-negative” lung adenocarcinomas (ADC) from patients with no smoking or a light smoking (NS/LS) history.
First Author: Alexander E. Drilon
Poster
2018 ASCO Annual Meeting
An amplicon-based liquid biopsy for detecting ALK and ROS1 fusions and resistance mutations in advanced non-small cell lung cancer (NSCLC) patients.
First Author: Laura Mezquita
Poster
2018 ASCO Annual Meeting
Economic impact of next generation sequencing vs sequential single-gene testing modalities to detect genomic alterations in metastatic non-small cell lung cancer using a decision analytic model.
First Author: Nathan A. Pennell